Yuji Hosono

Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy With High‐Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti–Melanoma Differentiation–Associated Gene 5–Positive Dermatomyositis

Hideaki Tsuji, Ran Nakashima, Yuji Hosono et al. · Arthritis & Rheumatology · 2019 · 361 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease

Hironao Hozumi, Tomoyuki Fujisawa, Ran Nakashima et al. · Respiratory Medicine · 2016 · 186 citations · Full text

Life Sciences, Immunology, Internal Medicine +16

HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibody

Kiminobu Tanizawa, Tomohiro Handa, Ran Nakashima et al. · Respiratory Medicine · 2011 · 138 citations · Full text

Medicine, Dermatology, Pathology +15

Efficacy of plasma exchange in anti-MDA5-positive dermatomyositis with interstitial lung disease under combined immunosuppressive treatment

Mirei Shirakashi, Ran Nakashima, Hideaki Tsuji et al. · Lara D. Veeken · 2020 · 135 citations

Medicine, Immunology, Pharmacology +15

Neutrophil dysregulation is pathogenic in idiopathic inflammatory myopathies

Nickie Seto, Carmelo Carmona‐Rivera, Iago Pinal‐Fernandez et al. · JCI Insight · 2020 · 133 citations · Full text

Life Sciences, Immunology, Pathology +17